# Century Therapeutics Posts $0.11 Q3 Loss Per Share as Net Loss Narrows

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/55652
Published: 2026-11-12T16:48:25.000Z
Updated: 2026-11-12T16:48:25.000Z
Section: Business

> The company had $174.1 million in cash, cash equivalents and investments at quarter-end and estimated the balance would support operations into the first quarter of 2029.

Century Therapeutics, Inc. recorded a GAAP loss of $0.11 per share for the third quarter ended Sept. 30, 2026, while its net loss narrowed from a year earlier.

Century’s net loss was $23.5 million, compared with $34.4 million in the same quarter a year earlier.

Cash, cash equivalents and investments totaled $174.1 million at quarter-end. Century estimated that balance would support operations into the first quarter of 2029.